Two-dose Soberana 02 with 62 percent efficacy
- Written by RHC
- Category: Cuba
- Hits: 853
Results from the trial of Cuba anti-Covid-19 vaccine candidate Soberana 02 are out. Its two-dose immunization scheme, after its Phase III trial, has achieved 62 percent efficacy, manufacturer BioCubaFarma announced Saturday.